nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Risedronate—PTGS2—pancreatic cancer	0.00382	0.529	CrCbGaD
Pamidronate—Clodronate—PTGS2—pancreatic cancer	0.00341	0.471	CrCbGaD
Pamidronate—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000623	0.000628	CcSEcCtD
Pamidronate—Body temperature increased—Irinotecan—pancreatic cancer	0.000617	0.000621	CcSEcCtD
Pamidronate—Abdominal pain—Irinotecan—pancreatic cancer	0.000617	0.000621	CcSEcCtD
Pamidronate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000616	0.00062	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000613	0.000617	CcSEcCtD
Pamidronate—Anaemia—Docetaxel—pancreatic cancer	0.000611	0.000615	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—pancreatic cancer	0.000606	0.000611	CcSEcCtD
Pamidronate—Vomiting—Sunitinib—pancreatic cancer	0.000602	0.000607	CcSEcCtD
Pamidronate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000601	0.000605	CcSEcCtD
Pamidronate—Neutropenia—Epirubicin—pancreatic cancer	0.000598	0.000603	CcSEcCtD
Pamidronate—Rash—Sunitinib—pancreatic cancer	0.000597	0.000602	CcSEcCtD
Pamidronate—Dermatitis—Sunitinib—pancreatic cancer	0.000597	0.000601	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000595	0.000599	CcSEcCtD
Pamidronate—Headache—Sunitinib—pancreatic cancer	0.000594	0.000598	CcSEcCtD
Pamidronate—Syncope—Docetaxel—pancreatic cancer	0.000593	0.000597	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—pancreatic cancer	0.000592	0.000596	CcSEcCtD
Pamidronate—Leukopenia—Docetaxel—pancreatic cancer	0.000592	0.000596	CcSEcCtD
Pamidronate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000591	0.000595	CcSEcCtD
Pamidronate—Loss of consciousness—Docetaxel—pancreatic cancer	0.000581	0.000585	CcSEcCtD
Pamidronate—Cough—Docetaxel—pancreatic cancer	0.000577	0.000581	CcSEcCtD
Pamidronate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000575	0.000579	CcSEcCtD
Pamidronate—Pneumonia—Epirubicin—pancreatic cancer	0.000574	0.000578	CcSEcCtD
Pamidronate—Convulsion—Docetaxel—pancreatic cancer	0.000573	0.000577	CcSEcCtD
Pamidronate—Hypertension—Docetaxel—pancreatic cancer	0.000571	0.000575	CcSEcCtD
Pamidronate—Infestation NOS—Epirubicin—pancreatic cancer	0.000571	0.000575	CcSEcCtD
Pamidronate—Infestation—Epirubicin—pancreatic cancer	0.000571	0.000575	CcSEcCtD
Pamidronate—Myalgia—Docetaxel—pancreatic cancer	0.000563	0.000567	CcSEcCtD
Pamidronate—Arthralgia—Docetaxel—pancreatic cancer	0.000563	0.000567	CcSEcCtD
Pamidronate—Nausea—Sunitinib—pancreatic cancer	0.000563	0.000567	CcSEcCtD
Pamidronate—Renal failure—Epirubicin—pancreatic cancer	0.000561	0.000565	CcSEcCtD
Pamidronate—Asthenia—Irinotecan—pancreatic cancer	0.00056	0.000564	CcSEcCtD
Pamidronate—Stomatitis—Epirubicin—pancreatic cancer	0.000556	0.00056	CcSEcCtD
Pamidronate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000555	0.000559	CcSEcCtD
Pamidronate—Urinary tract infection—Epirubicin—pancreatic cancer	0.000555	0.000559	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—pancreatic cancer	0.000554	0.000558	CcSEcCtD
Pamidronate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000551	0.000555	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00055	0.000554	CcSEcCtD
Pamidronate—Asthenia—Gemcitabine—pancreatic cancer	0.000545	0.000549	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—pancreatic cancer	0.000544	0.000548	CcSEcCtD
Pamidronate—Confusional state—Docetaxel—pancreatic cancer	0.000544	0.000548	CcSEcCtD
Pamidronate—Oedema—Docetaxel—pancreatic cancer	0.000539	0.000543	CcSEcCtD
Pamidronate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000539	0.000543	CcSEcCtD
Pamidronate—Pruritus—Gemcitabine—pancreatic cancer	0.000538	0.000542	CcSEcCtD
Pamidronate—Infection—Docetaxel—pancreatic cancer	0.000536	0.00054	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—pancreatic cancer	0.000535	0.000539	CcSEcCtD
Pamidronate—Diarrhoea—Irinotecan—pancreatic cancer	0.000534	0.000538	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—pancreatic cancer	0.000532	0.000536	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—pancreatic cancer	0.000531	0.000535	CcSEcCtD
Pamidronate—Shock—Docetaxel—pancreatic cancer	0.000531	0.000535	CcSEcCtD
Pamidronate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000529	0.000533	CcSEcCtD
Pamidronate—Pruritus—Fluorouracil—pancreatic cancer	0.000529	0.000533	CcSEcCtD
Pamidronate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000528	0.000532	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—pancreatic cancer	0.000528	0.000532	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—pancreatic cancer	0.000528	0.000532	CcSEcCtD
Pamidronate—Tachycardia—Docetaxel—pancreatic cancer	0.000527	0.00053	CcSEcCtD
Pamidronate—Diarrhoea—Gemcitabine—pancreatic cancer	0.00052	0.000524	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—pancreatic cancer	0.000519	0.000523	CcSEcCtD
Pamidronate—Dizziness—Irinotecan—pancreatic cancer	0.000516	0.00052	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—pancreatic cancer	0.000515	0.000519	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—pancreatic cancer	0.000515	0.000518	CcSEcCtD
Pamidronate—Anorexia—Docetaxel—pancreatic cancer	0.000514	0.000518	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—pancreatic cancer	0.000513	0.000517	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000513	0.000517	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000513	0.000517	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—pancreatic cancer	0.000512	0.000516	CcSEcCtD
Pamidronate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000511	0.000515	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000506	0.000509	CcSEcCtD
Pamidronate—Hypotension—Docetaxel—pancreatic cancer	0.000504	0.000508	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—pancreatic cancer	0.000503	0.000507	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000503	0.000507	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—pancreatic cancer	0.000502	0.000506	CcSEcCtD
Pamidronate—Vomiting—Irinotecan—pancreatic cancer	0.000496	0.0005	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—pancreatic cancer	0.000495	0.000499	CcSEcCtD
Pamidronate—Dizziness—Fluorouracil—pancreatic cancer	0.000494	0.000498	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000493	0.000496	CcSEcCtD
Pamidronate—Rash—Irinotecan—pancreatic cancer	0.000492	0.000496	CcSEcCtD
Pamidronate—Dermatitis—Irinotecan—pancreatic cancer	0.000492	0.000495	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000491	0.000495	CcSEcCtD
Pamidronate—Headache—Irinotecan—pancreatic cancer	0.000489	0.000492	CcSEcCtD
Pamidronate—Insomnia—Docetaxel—pancreatic cancer	0.000488	0.000491	CcSEcCtD
Pamidronate—Paraesthesia—Docetaxel—pancreatic cancer	0.000484	0.000488	CcSEcCtD
Pamidronate—Vomiting—Gemcitabine—pancreatic cancer	0.000483	0.000487	CcSEcCtD
Pamidronate—Dyspnoea—Docetaxel—pancreatic cancer	0.000481	0.000484	CcSEcCtD
Pamidronate—Somnolence—Docetaxel—pancreatic cancer	0.00048	0.000483	CcSEcCtD
Pamidronate—Rash—Gemcitabine—pancreatic cancer	0.000479	0.000483	CcSEcCtD
Pamidronate—Dermatitis—Gemcitabine—pancreatic cancer	0.000479	0.000482	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—pancreatic cancer	0.000479	0.000482	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000476	0.00048	CcSEcCtD
Pamidronate—Headache—Gemcitabine—pancreatic cancer	0.000476	0.00048	CcSEcCtD
Pamidronate—Flushing—Epirubicin—pancreatic cancer	0.000475	0.000479	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000475	0.000479	CcSEcCtD
Pamidronate—Vomiting—Fluorouracil—pancreatic cancer	0.000475	0.000479	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—pancreatic cancer	0.000475	0.000479	CcSEcCtD
Pamidronate—Dyspepsia—Docetaxel—pancreatic cancer	0.000475	0.000478	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000474	0.000477	CcSEcCtD
Pamidronate—Rash—Fluorouracil—pancreatic cancer	0.000471	0.000475	CcSEcCtD
Pamidronate—Dermatitis—Fluorouracil—pancreatic cancer	0.000471	0.000474	CcSEcCtD
Pamidronate—Decreased appetite—Docetaxel—pancreatic cancer	0.000469	0.000472	CcSEcCtD
Pamidronate—Headache—Fluorouracil—pancreatic cancer	0.000468	0.000472	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000468	0.000471	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000466	0.000469	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000466	0.000469	CcSEcCtD
Pamidronate—Fatigue—Docetaxel—pancreatic cancer	0.000465	0.000468	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—pancreatic cancer	0.000465	0.000468	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000465	0.000468	CcSEcCtD
Pamidronate—Nausea—Irinotecan—pancreatic cancer	0.000464	0.000467	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—pancreatic cancer	0.000463	0.000466	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000462	0.000465	CcSEcCtD
Pamidronate—Constipation—Docetaxel—pancreatic cancer	0.000461	0.000465	CcSEcCtD
Pamidronate—Pain—Docetaxel—pancreatic cancer	0.000461	0.000465	CcSEcCtD
Pamidronate—Chills—Epirubicin—pancreatic cancer	0.00046	0.000463	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—pancreatic cancer	0.000453	0.000456	CcSEcCtD
Pamidronate—Nausea—Gemcitabine—pancreatic cancer	0.000452	0.000455	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—pancreatic cancer	0.000446	0.000449	CcSEcCtD
Pamidronate—Erythema—Epirubicin—pancreatic cancer	0.000446	0.000449	CcSEcCtD
Pamidronate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000445	0.000448	CcSEcCtD
Pamidronate—Nausea—Fluorouracil—pancreatic cancer	0.000444	0.000447	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—pancreatic cancer	0.000443	0.000446	CcSEcCtD
Pamidronate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000441	0.000444	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00044	0.000443	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—pancreatic cancer	0.00044	0.000443	CcSEcCtD
Pamidronate—Tension—Epirubicin—pancreatic cancer	0.000438	0.000441	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—pancreatic cancer	0.000437	0.00044	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—pancreatic cancer	0.000433	0.000436	CcSEcCtD
Pamidronate—Back pain—Epirubicin—pancreatic cancer	0.000431	0.000434	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—pancreatic cancer	0.00043	0.000433	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—pancreatic cancer	0.000429	0.000432	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000428	0.000431	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000427	0.00043	CcSEcCtD
Pamidronate—Abdominal pain—Docetaxel—pancreatic cancer	0.000426	0.00043	CcSEcCtD
Pamidronate—Body temperature increased—Docetaxel—pancreatic cancer	0.000426	0.00043	CcSEcCtD
Pamidronate—Chills—Doxorubicin—pancreatic cancer	0.000425	0.000428	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—pancreatic cancer	0.000419	0.000422	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000414	0.000417	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—pancreatic cancer	0.000413	0.000416	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—pancreatic cancer	0.000413	0.000416	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—pancreatic cancer	0.000412	0.000415	CcSEcCtD
Pamidronate—Agitation—Epirubicin—pancreatic cancer	0.00041	0.000413	CcSEcCtD
Pamidronate—Tension—Doxorubicin—pancreatic cancer	0.000405	0.000408	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000404	0.000407	CcSEcCtD
Pamidronate—Malaise—Epirubicin—pancreatic cancer	0.000402	0.000405	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—pancreatic cancer	0.000401	0.000404	CcSEcCtD
Pamidronate—Syncope—Epirubicin—pancreatic cancer	0.0004	0.000403	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—pancreatic cancer	0.000399	0.000402	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—pancreatic cancer	0.000399	0.000402	CcSEcCtD
Pamidronate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000397	0.0004	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000397	0.0004	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000392	0.000395	CcSEcCtD
Pamidronate—Cough—Epirubicin—pancreatic cancer	0.000389	0.000392	CcSEcCtD
Pamidronate—Asthenia—Docetaxel—pancreatic cancer	0.000387	0.00039	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—pancreatic cancer	0.000386	0.000389	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—pancreatic cancer	0.000385	0.000388	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000383	0.000386	CcSEcCtD
Pamidronate—Pruritus—Docetaxel—pancreatic cancer	0.000382	0.000384	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—pancreatic cancer	0.000381	0.000384	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—pancreatic cancer	0.00038	0.000382	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—pancreatic cancer	0.00038	0.000382	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—pancreatic cancer	0.000379	0.000382	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—pancreatic cancer	0.000378	0.000381	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—pancreatic cancer	0.000375	0.000378	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—pancreatic cancer	0.000372	0.000375	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—pancreatic cancer	0.00037	0.000373	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—pancreatic cancer	0.000369	0.000372	CcSEcCtD
Pamidronate—Diarrhoea—Docetaxel—pancreatic cancer	0.000369	0.000372	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—pancreatic cancer	0.000367	0.00037	CcSEcCtD
Pamidronate—Oedema—Epirubicin—pancreatic cancer	0.000364	0.000367	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000364	0.000367	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000363	0.000365	CcSEcCtD
Pamidronate—Infection—Epirubicin—pancreatic cancer	0.000361	0.000364	CcSEcCtD
Pamidronate—Cough—Doxorubicin—pancreatic cancer	0.00036	0.000363	CcSEcCtD
Pamidronate—Shock—Epirubicin—pancreatic cancer	0.000358	0.000361	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—pancreatic cancer	0.000357	0.00036	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000357	0.000359	CcSEcCtD
Pamidronate—Dizziness—Docetaxel—pancreatic cancer	0.000357	0.000359	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000356	0.000359	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—pancreatic cancer	0.000356	0.000359	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—pancreatic cancer	0.000355	0.000358	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000352	0.000354	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—pancreatic cancer	0.000351	0.000354	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—pancreatic cancer	0.000351	0.000354	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—pancreatic cancer	0.00035	0.000353	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—pancreatic cancer	0.000347	0.00035	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—pancreatic cancer	0.000347	0.000349	CcSEcCtD
Pamidronate—Vomiting—Docetaxel—pancreatic cancer	0.000343	0.000345	CcSEcCtD
Pamidronate—Rash—Docetaxel—pancreatic cancer	0.00034	0.000343	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—pancreatic cancer	0.00034	0.000342	CcSEcCtD
Pamidronate—Dermatitis—Docetaxel—pancreatic cancer	0.00034	0.000342	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—pancreatic cancer	0.000339	0.000342	CcSEcCtD
Pamidronate—Headache—Docetaxel—pancreatic cancer	0.000338	0.00034	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—pancreatic cancer	0.000337	0.000339	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000337	0.000339	CcSEcCtD
Pamidronate—Infection—Doxorubicin—pancreatic cancer	0.000334	0.000337	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000332	0.000334	CcSEcCtD
Pamidronate—Shock—Doxorubicin—pancreatic cancer	0.000331	0.000334	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00033	0.000333	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00033	0.000332	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—pancreatic cancer	0.000329	0.000331	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—pancreatic cancer	0.000329	0.000331	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—pancreatic cancer	0.000327	0.000329	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000325	0.000328	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—pancreatic cancer	0.000324	0.000327	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—pancreatic cancer	0.000323	0.000326	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—pancreatic cancer	0.000321	0.000323	CcSEcCtD
Pamidronate—Nausea—Docetaxel—pancreatic cancer	0.00032	0.000323	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—pancreatic cancer	0.00032	0.000323	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—pancreatic cancer	0.000316	0.000319	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—pancreatic cancer	0.000315	0.000317	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000314	0.000316	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—pancreatic cancer	0.000314	0.000316	CcSEcCtD
Pamidronate—Pain—Epirubicin—pancreatic cancer	0.000311	0.000313	CcSEcCtD
Pamidronate—Constipation—Epirubicin—pancreatic cancer	0.000311	0.000313	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000307	0.000309	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—pancreatic cancer	0.000305	0.000307	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000302	0.000305	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—pancreatic cancer	0.0003	0.000302	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—pancreatic cancer	0.0003	0.000302	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—pancreatic cancer	0.000299	0.000301	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000298	0.0003	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000296	0.000299	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000293	0.000295	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000291	0.000293	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—pancreatic cancer	0.00029	0.000292	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—pancreatic cancer	0.000288	0.00029	CcSEcCtD
Pamidronate—Pain—Doxorubicin—pancreatic cancer	0.000288	0.00029	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—pancreatic cancer	0.000288	0.00029	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—pancreatic cancer	0.000288	0.00029	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000277	0.000279	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000275	0.000277	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000268	0.00027	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000266	0.000268	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000266	0.000268	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—pancreatic cancer	0.000261	0.000263	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—pancreatic cancer	0.000257	0.000259	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—pancreatic cancer	0.000249	0.000251	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000248	0.00025	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—pancreatic cancer	0.000242	0.000243	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—pancreatic cancer	0.000241	0.000242	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—pancreatic cancer	0.000238	0.00024	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—pancreatic cancer	0.000231	0.000233	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—pancreatic cancer	0.00023	0.000232	CcSEcCtD
Pamidronate—Rash—Epirubicin—pancreatic cancer	0.000229	0.000231	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—pancreatic cancer	0.000229	0.000231	CcSEcCtD
Pamidronate—Headache—Epirubicin—pancreatic cancer	0.000228	0.00023	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—pancreatic cancer	0.000223	0.000224	CcSEcCtD
Pamidronate—Nausea—Epirubicin—pancreatic cancer	0.000216	0.000218	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—pancreatic cancer	0.000214	0.000216	CcSEcCtD
Pamidronate—Rash—Doxorubicin—pancreatic cancer	0.000212	0.000214	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—pancreatic cancer	0.000212	0.000214	CcSEcCtD
Pamidronate—Headache—Doxorubicin—pancreatic cancer	0.000211	0.000212	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—pancreatic cancer	0.0002	0.000201	CcSEcCtD
